Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
Li Wang, Markus H. Kainulainen, Nannan Jiang, Han Di, Gaston Bonenfant, Lisa Mills, Michael Currier, Punya Shrivastava-Ranjan, Brenda M. Calderon, Mili Sheth, Brian R. Mann, Jaber Hossain, Xudong Lin, Sandra Lester, Elizabeth Pusch, Joyce Jones, Dan Cui, Payel Chatterjee, Harley M. Jenks, Esther Morantz, Gloria Larson, Masato Hatta, Jennifer Harcourt, Azaibi Tamin, Yan Li, Ying Tao, Kun Zhao, Kristine Lacek, Ashely Burroughs, Terianne Wong, Suxiang Tong, John R. Barnes, Mark W. Tenforde, Wesley H. Self, Nathan I. Shapiro, Matthew C. Exline, D. Clark Files, Kevin W. Gibbs, David N. Hager, Manish Patel, Alison S. Laufer Halpin, Laura K. McMullan, Justin S. Lee, Xuping Xie, Pei-Yong Shi, C. Todd Davis, Christina F. Spiropoulou, Natalie J. Thornburg, M. Steven Oberste, Vivien Dugan, SSEV Bioinformatics Working Group, David E. Wentworth, Bin Zhou
bioRxiv 2021.11.24.469906; doi: https://doi.org/10.1101/2021.11.24.469906